Dementia (Primer on)

個数:
電子版価格
¥14,421
  • 電子版あり

Dementia (Primer on)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 328 p.
  • 言語 ENG
  • 商品コード 9780197690024
  • DDC分類 616.831

Full Description

Adults 65 and older are the fastest growing segment of the population worldwide, which means there will be more people living with mild cognitive impairment and dementia. Written at a resident level, the Primer on Dementia provides early career professionals with the information necessary to care for the often complex clinical presentations of people with age-associated neurocognitive disorders.

This book is organized into three sections: (1) core concepts, (2) dementia syndromes, and (3) disease management. The chapters in section one focus on clinical knowledge and skills applicable across all dementias, including the diagnostic interview and neurologic examination, frequently used cognitive screening measures, neuropsychological assessment, neuroimaging, and differential diagnosis. Chapters in section two review the most common dementia syndromes and cover epidemiology, neuropathology, biomarkers, genetics, and clinical signs and symptoms, providing at least one illustrative case. The final section presents the latest evidence-based interventions from risk management to pharmacologic and nonpharmacologic approaches, while also addressing safety considerations, legal issues, palliative and advanced care planning, and attending to caregivers.

Contents

Introduction and Overview
Robin C. Hilsabeck and Gayle Ayers

Section I: Core Concepts
1. Epidemiology, Risk Factors, and Disease Burden
Jason E. Schillerstrom, Kimberly S. Benavente, and Ivelisse M. Velazquez-Negron

2. Diagnostic Interviewing and Cognitive Screening
Phillip K. Martin, Kamalakar Surineni, and Ryan W. Schroeder

3. Neuropsychological Assessment
Gabrielle A. Hromas and Jeremy J. Davis

4. Neurologic Exam
Sethulakshmi Sreevalsam Anil and Badr Ratnakaran

5. Neuroimaging
Mary A. Kelley and John A. Bertelson

6. Differential Diagnosis
Emily J. MacKillop and Heather E. McNeely

Section II: Age-Associated Neurocognitive Disorders
7. Mild Cognitive Impairment
Alec Neale, Jenna Axelrod, Elizabeth Geary, and Leslie M. Guidotti-Breting

8. Alzheimer's Disease
Kyle J. Jennette and Jason R. Soble

9. Vascular Disease
Seetha Chandrasekhara and Danna L. Zevy

10. Frontotemporal Lobular Degeneration
Angelina J. Polsinelli, Dale Korinek, Elizabeth K. Vernon, and Sophia Wang

11. Lewy Body Disease and Atypical Parkinsonian Conditions
Bonnie M. Scott and Jared F. Benge

12. Rare and Rapidly Progressive Dementias
Joel E. Kamper, Emily N. VanDerBleek, and Erin K. Bailey

13. Dementia due to Other Medical Conditions
Channing A. Sofko and Katya Nama

Section III: Disease Management
14. Risk Management
Aaron Bonner-Jackson

15. Pharmacological Treatment
Deanna Fernandes and Josepha Cheong

16. Non-pharmacological Approaches -
Yesenia Serrano, Marie C. Weil, and Stephanie A. Tuncel

17. Safety Considerations
Joseph J. Asper, Alyssa C. Smith, Angelina J. Polsinelli, and Sophia Wang

18. Palliative and Advanced Care Planning
Adithy S. Nagarajan, Brian Donley, and Erica C. Garcia-Pittman

19. Legal Issues
Senthil Vel Rajan Rajaram Manoharan MBBS, Jessy Walia, and Mack Bozman

20. Attending to the Caregiver
Shannon Reilly, Brianna Daranciang, and Kathleen Fuchs